Dean Rubber Manufacturing Company v. United States

356 F.2d 161, 1966 U.S. App. LEXIS 7236
CourtCourt of Appeals for the Eighth Circuit
DecidedFebruary 8, 1966
Docket17855_1
StatusPublished
Cited by13 cases

This text of 356 F.2d 161 (Dean Rubber Manufacturing Company v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dean Rubber Manufacturing Company v. United States, 356 F.2d 161, 1966 U.S. App. LEXIS 7236 (8th Cir. 1966).

Opinion

MEHAFFY, Circuit Judge.

Dean Rubber Manufacturing Company, a partnership, was tried to a jury under a ten-count information charging separate violations of the Federal Food, Drug and Cosmetic Act, 21 U.S.C.A. § 331(a). 1 Five counts charged the interstate shipment of “adulterated” prophylactics 2 and five counts charged the interstate shipment of “misbranded” prophylactics. 3

Defendant was convicted on the adulteration counts but acquitted of mis-branding. The prophylactics were labeled “An aid in the prevention of venereal disease,” despite the fact that some were found to have holes.

The crimes charged were misdemeanors and upon the jury’s verdict, the District Court entered judgment of conviction and assessed fines for each violation. We affirm.

Defendant first asserts that the representation, “An aid in prevention of venereal disease,” is not a claim of “quality” within the meaning of subsection 351(c), as it is not an expression of *163 measurable component parts. Instead, the clause is a therapeutic claim warranting only that the prophylactic has a tendency to prevent venereal disease. We consider this argument hypertechnical as it would unduly inhibit the meaning of “quality” as used in the statute. While “quality” is descriptive of the organic composition of a substance, expressed in definite quantitative units, it is also definitive of the character, nature and degree of excellence of an article. Such is the general understanding and the dictionary definition of the word. Even the bare name of the device, “prophylactic,” connotes a guard against or prevention of disease. The failure of a leaking prophylactic to prevent disease is manifest and does not require our elaboration.

In United States v. 431/2 Gross Rubber Prophylactics, 65 F.Supp. 534 (D.C.Minn. 1946), aff’d. sub nom. Gellman v. United States, 159 F.2d 881 (8th Cir. 1947), a condemnation proceeding under subsection 351(c), the devices contained holes and were labeled only “prophylactics.” That Court said:

“The government inspection has established that the devices tested were defective in the number indicated, and there can be no serious doubt that the strength and quality of these particular defective articles fell below that which they purported or were represented to possess.” Id. at. 535.

We have examined the eases cited by defendant and find them to be inapposite. We conclude that the interstate shipment of prophylactics, having holes and failing to meet Government specifications, violates subsection 331(a) by having a lower quality than that professed through written expression and inherent meaning.

Defendant next contends that subsection 351(c) applies solely to drugs and not to devices. It is argued that subsection (b) applies only to official compendium drugs, and that subsection (c) is limited to drugs not subject to subsection (b); thus devices are excluded from the purview of subsection (c). This is not the intent of Congress. It is most improbable that Congress would pass an adulteration statute whose first sentence embraces both drugs and devices, and then confine adulterated devices to those which are also misbranded. This runs contrary to the purpose of the Act and fails to eliminate those evils which it was designed to eliminate. Section 351 begins : “A drug or device shall be deemed to be adulterated' — .” Adulteration is then defined in four subsections. The only one applicable to misrepresented devices is subsection (c) which clearly applies to devices as well as to drugs not listed in the official compendium mentioned in subsection (b). If language specifically referring only to drugs and contaminated devices is eliminated from the statute, it would read “ [any] drug or device shall be deemed to be adulterated * * * if its strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.”

We have heretofore called attention to Gellman v. United States, supra, sustaining a condemnation of defective prophylactics pursuant to subsection 351(c). It is noteworthy that the provisions dealing solely with drugs preface such provisions by the phrase, “if it is a drug.” See, for example, 21 U.S.C.A. § 351(a) (3); 21 U.S.C.A. § 351(b) and (d).

Defendant would bolster its interpretation by using the headnote between subsections (b) and (c) because it does not mention “device.” This, however, is not a part of the official Act of Congress and is entitled to no consideration in interpreting congressional intent.

Additionally, defendant would invoke the 1962 amendment, 76 Stat. 780, to support its interpretation. However, the 1962 Act has no effect on subsection 351 (c), as it was adopted to strengthen subsection 351(a), and clearly does not apply to devices. Its passage lends no support to the theory that subsection 351 (c) does not include the definition of adulterated devices.

The Supreme Court announces the purpose of the Act as the protection of pub- *164 lie health and admonishes that “[r]egard for [this purpose] should infuse construction of the legislation if it is to be treated as a working instrument of government and not merely as a collection of English words.” United States v. Dotterweich, 320 U.S. 277, 280, 64 S.Ct. 134, 136, 88 L.Ed. 48 (1943).

Nothing on the face of subsection 351(c) limits its application to drugs and we conclude that the subsection applies to devices as well as those drugs not subject to the provisions of subsection (b).

Defendant also assails the constitutionality of the Act as enforced by the Government. It is claimed that the Government charges as violative only shipments of defective devices in excess of an unannounced and changing tolerance, thereby introducing elements of uncertainty and vagueness which are inconsistent with constitutional due process and cause the Act to operate ex post facto.

Despite the statutory proscription against the interstate shipment of a single adulterated device, defendant and other manufacturers of prophylactics are given the benefit of an administrative tolerance. The industry manufactures billons of prophylactics each year, making it impractical, imprudent and injudicious for the Food and Drug Administration to prosecute for the shipment of a single defective prophylactic.

As a practical solution, the Administrator adopted a working tolerance of 1% and prosecutes an interstate shipper only if the shipment contains an excess of the allowed variance. The tolerance has changed from time to time since adoption of the Act in 1938. A 1% tolerance has been in effect since July 1, 1957.

The Act gives the Secretary the discretion to refrain from prosecuting a minor violation whenever he believes that the public interest will be adequately served by a suitable written notice or warning. 4 The procedure benefits defendant and other manufacturers as well as the Food and Drug Administration.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
356 F.2d 161, 1966 U.S. App. LEXIS 7236, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dean-rubber-manufacturing-company-v-united-states-ca8-1966.